scorecardresearch
Wednesday, November 6, 2024
TopicDiabetes

Topic: Diabetes

Using smartwatch to monitor blood glucose level? US FDA strongly advises against it

US regulator says devices that claim to monitor blood glucose levels in real time without piercing skin may show inaccurate & misleading results and pose risks for people with diabetes.

Can diabetes be ‘reversed’ and who is the ideal candidate? What doctors, health-tech firms say

Research suggests Type 2 diabetes can be 'reversed' early on, but doctors stress importance of healthy habits & say health-tech startups' programmes should be approached cautiously.

India denies nod to ‘1st-ever weekly insulin’ for diabetics, seeks more info from maker Novo Nordisk

Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.

Diabetes drug semaglutide offers hope beyond obesity management — kidney, heart & liver health

Study by Australian & Canadian scientists, published in Kidney International, finds that drug may be effective at reducing inflammation — lowering risk of heart & kidney disease.

Can taking salt off the table help prevent diabetes? It’s not that simple

Normal salt intake in countries like the UK is about 2 teaspoons a day. But about three-quarters of this comes from processed foods.

Air pollution linked to surging Type 2 diabetes cases, finds 7-yr study of Delhi & Chennai residents

Findings are 1st evidence from India linking high PM2.5 levels in ambient air with rising blood sugar levels. Study by Indian & US researchers published in British Medical Journal.

‘Diabetes capital’ India slated to get world’s 1st once-a-week insulin ‘by 2025’

Danish pharma giant Novo Nordisk's Icodec could be game-changer for diabetics. The drug is nearing regulatory approval in US & EU, says company.

Weight loss ‘wonder drug’ semaglutide can cut down risk of heart disease, says Danish drugmaker

Novo Nordisk says results of its trials show a 2.4 mg dose can cut down major heart-related ailments by 20%, and the study will be published in a peer-reviewed journal by end of year.

Ultra-processed food doubles risk of death by cardiovascular disease in diabetics, 12-yr study says

The first-of-its-kind study published last week in the the 'American Journal of Clinical Nutrition' was conducted by Italian researchers among over 1,000 participants.

Amid US reports of stomach paralysis due to weight-loss ‘wonder drug’, doctors say such side-effects rare

Semaglutide, which is available in India as a pill and in other countries as an injection, has some known side effects but they are usually mild and short-lived, say doctors.

On Camera

What Trump-Harris result could mean for India in key areas, from geopolitics to trade & immigration

India cannot be blasé about change in any important capital in the world. Let's look at five key areas where US policy matters for India and how it may vary between Harris and Trump.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

Rifles slung upside down, on ponies. Indian troops go on their 1st patrol in Depsang since 2020

Troops patrolled up to Patrolling Point (PP) 10 on Monday. Though there are PP 10, 11, 12, 12A & 13 in Depsang Plains, it was decided that only one or two PPs would be patrolled.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.